Key result
TRPA1 activation reduces ischemia-induced cardiomyocyte death via an eNOS-dependent pathway.
Why the study?
Whether TRPA1 induces nitric oxide production in cardiomyocytes and whether this cascade mediates physiological or pathophysiological cardiac events remained elusive.
TRPA1 activation provides cardioprotection against ischemic injury through an Akt/eNOS/NO signaling pathway that operates independently of its well-known positive inotropic effects.
Answers are grounded in this paper and cite their sources.
May warrant preclinical testing of TRPA1 agonists in ischemia; leaves open translation to in vivo or clinical settings.
The functional expression of transient receptor potential cation channel of the ankyrin-1 subtype (TRPA1) has recently been identified in adult mouse cardiac tissue where stimulation of this ion channel leads to increases in adult mouse ventricular cardiomyocyte (CM) contractile function via a Ca2+-Calmodulin-dependent kinase (CaMKII) pathway. However, the extent to which TRPA1 induces nitric oxide (NO) production in CMs, and whether this signaling cascade mediates physiological or pathophysiological events in cardiac tissue remains elusive. Freshly isolated CMs from wild-type (WT) or TRPA1 knockout (TRPA1-/-) mouse hearts were treated with AITC (100 µM) and prepared for immunoblot, NO detection or ischemia protocols. Our findings demonstrate that TRPA1 stimulation with AITC results in phosphorylation of protein kinase B (Akt) and endothelial NOS (eNOS) concomitantly with NO production in a concentration- and time-dependent manner. Additionally, we found that TRPA1 induced increases in CM [Ca2+]i and contractility occur independently of Akt and eNOS activation mechanisms. Further analysis revealed that the presence and activation of TRPA1 promotes CM survival and viability following ischemic insult via a mechanism partially dependent upon eNOS. Therefore, activation of the TRPA1/Akt/eNOS pathway attenuates ischemia-induced CM cell death.
No takes yet. Share an insight, caveat, or question.
Andrei et al. (2019) studied Ischemia-induced cardiomyocyte cell death. AITC vs. Vehicle (ethanol) and knockout controls was evaluated on Ischemia-induced cardiomyocyte cell death. Activation of TRPA1 with AITC attenuated ischemia-induced cardiomyocyte cell death and promoted survival through a mechanism partially dependent upon eNOS.
Synapse has enriched 10 related papers. Consider them for comparative context: